Location History:
- Pahl, DE (1990)
- Feldafing, DE (1999 - 2022)
Company Filing History:
3 out of 1,164 
3 out of 1,651 
2 out of 480 
Years Active: 1990-2022
Title: Rosemarie Kientsch-Engel: Innovator in Medical Diagnostics
Introduction
Rosemarie Kientsch-Engel is a prominent inventor based in Feldafing, Germany. She has made significant contributions to the field of medical diagnostics, holding a total of 8 patents. Her work focuses on innovative methods for predicting and diagnosing critical health conditions.
Latest Patents
One of her latest patents involves the use of IGFBP7 for predicting the risk of acute kidney injury (AKI) when measured prior to surgery. This method is based on determining the level of the biomarker IGFBP7 in a body fluid sample obtained from the patient. Additionally, she has developed a method for predicting AKI risk based on the determination of both IGFBP7 and Cystatin C levels. Another significant patent relates to H-FABP as an early predictor of myocardial infarction. This invention provides a method for diagnosing myocardial infarction in subjects suffering from acute coronary syndrome, particularly when cardiac troponin levels are detectable but lower than the indicative level for myocardial infarction.
Career Highlights
Throughout her career, Rosemarie has worked with notable companies such as Boehringer Mannheim GmbH and Roche Diagnostics Operations, Inc. Her expertise in medical diagnostics has led to groundbreaking advancements in patient care and treatment protocols.
Collaborations
Rosemarie has collaborated with esteemed colleagues, including Josef Endl and Michael Brandt, contributing to the development of innovative diagnostic methods.
Conclusion
Rosemarie Kientsch-Engel's contributions to medical diagnostics through her patents and collaborations have significantly impacted the field. Her innovative approaches continue to enhance patient outcomes and advance medical technology.